LUCIA BIO
Who is LUCIA BIO?
Lucia Bio is developing highly selective spleen tyrosine kinase (Syk) inhibitors for potential application in peripheral immunology, neurology and haematology oncology. A collaboration between the University of Queensland Emory Drug Discovery Initiative (QEDDI) and Molecule to Medicine (MTM), Lucia...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
BRISBANE, AU
Employees by Department
- Operations (1)
- The Rest (1)
- Total (2)
Key Decision Makers
Georgia Palmer
Business Operations Manager & R&D Project Manager
Gregg Smith
Senior Drug Development Advisor
Insight
Signals
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
0employees
Senior
1employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has LUCIA BIO been operating for?
- What is the funding status of LUCIA BIO?
- Where is LUCIA BIO's headquarter?
- What LUCIA BIO's spending power?
- Does LUCIA BIO have a presence in the domain it operates in?